Advanced Medical Solutions Group plc announced that it has received 510(k) approval from the US FDA for the Group's LiquiBand® Rapid™ product. The product will be commercialised immediately through one of AMS's main US partners and will upgrade this partner's offering. The Group expects LiquiBand® Rapid™ to enable AMS to regain ground with an improved product. LiquiBand® Rapid™ is a further portfolio extension of AMS's LiquiBand range, with a faster drying time than comparative products and multiple uses in operating room and emergency room settings. The approval of LiquiBand® Rapid™ is an important development for LiquiBand product range. Innovation remains a key driver of organic growth for the Group and this approval demonstrates the capabilities of internal R&D and regulatory teams. The Group remains confident of the growth potential for the LiquiBand® range alongside multiple other woundcare and surgical opportunities including those arising from the acquisitions of Biomatlante and Sealantis.